China Pharma Holdings, Inc. (CPHI)

CIK 0001106644 · Healthcare · Drug Manufacturers

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —
Q2-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Document and Entity Information
—
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statements of Operations and Comprehensive Loss (P)
Consolidated Statements of Stockholders Equity
Consolidated Statements of Cash Flows
Notes
Accounts Receivable, Net
Commitments and Contingencies
Convertible Note Payable
Cybersecurity Risk Management and Strategy Disclosure
—
Fair Value Measurements
Income Taxes
Insider Trading Arrangements
Intangible Assets
Inventories
Inventory
Leases
Lines of Credit
Lines of Credit and Construction Loan Facility
—
Loss Per Share
Organization and Significant Accounting Policies
Other Payables
Pay Vs Performance Disclosure
Property, Plant and Equipment
Related Party Transactions
Risks & Uncertainties
Stockholders' Equity
Subsequent Events